Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.
| Distributed by / for | Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810 |
| NDC | 65862-0560-90 |
| Full product label | Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90 |
| Recalling firm | Aurobindo Pharma USA Inc |
| Distribution | CA |
| Quantity | 23016 bottles |
| Recall initiated | 2016-08-03 |
| Report date | 2016-09-21 |
| Recall completed | 2018-06-08 |
| Recall number | D-1499-2016 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Plainsboro NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗